ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,070.55
      1.20%
      US Tech 100
      17,080.40
      0.46%
      Dow Jones
      38,503.69
      0.69%
      Brent Oil
      87.215
      -0.40%
      Bitcoin
      66,310.08
      -0.15%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. Inhibrx Inc (INBX)

      7. Inhibrx Inc (INBX) News

      INBX Inhibrx Inc

      34.13
      0.00 (0.00%)
      Pre Market
      Last Updated: 04:05:27
      Delayed by 15 minutes
      Company Name Stock Ticker Symbol Market Type
      Inhibrx Inc INBX NASDAQ Common Stock
        Price Change Change Percent Stock Price Last Traded
      Upgrade Icon
      0.00 0.00% 34.13 04:05:27
      Open Price Low Price High Price Close Price Prev Close
      34.13
      more quote information »

      Recent News

      Date Time Source Heading
      3/11/202416:26EDGAR2Form 144 - Report of proposed sale of securities
      3/08/202416:08EDGAR2Form 144 - Report of proposed sale of securities
      3/08/202415:28EDGAR2Form 144 - Report of proposed sale of securities
      3/06/202416:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
      3/05/202414:58EDGAR2Form 144 - Report of proposed sale of securities
      3/04/202418:26EDGAR2Form 144 - Report of proposed sale of securities
      2/29/202417:26EDGAR2Form PREM14A - Preliminary proxy statements relating to..
      2/28/202409:15PRNUSInhibrx Reports Fourth Quarter and Fiscal Year 2023..
      2/28/202409:12EDGAR2Form 8-K - Current report
      2/28/202409:10EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
      2/14/202416:12EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
      2/06/202416:30EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/26/202412:12PRNUSKuehn Law Encourages DOC, BATL, KAMN, and INBX Investors to..
      1/23/202417:25EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/23/202406:38EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
      1/23/202406:35EDGAR2Form 8-K - Current report
      1/23/202406:05DJNSanofi to Buy Assets From Inhibrx in Deal Valued at Up to..
      1/23/202405:40IHMARKETNEWSWall Street Highlights: Vroom Shuts Down Online Car Sales,..
      1/23/202401:00PRNUSInhibrx Announces Sale of INBRX-101 to Sanofi for an..
      11/09/202316:03EDGAR2Form 8-K - Current report
      11/09/202316:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      11/09/202316:00PRNUSInhibrx Reports Third Quarter 2023 Financial Results and..
      11/02/202309:16EDGAR2Form 8-K - Current report
      11/02/202309:15PRNUSInhibrx Announces Preliminary Data from the Phase 1 Trial of..
      10/18/202316:00PRNUSInhibrx Announces Participation in Upcoming Scientific..
      9/19/202316:03EDGAR2Form 8-K - Current report
      9/19/202316:00PRNUSInhibrx Retains Rights to INBRX-101 for the Treatment of..
      8/31/202316:06EDGAR2Form D - Notice of Exempt Offering of Securities
      8/29/202309:03EDGAR2Form 8-K - Current report
      8/29/202309:00PRNUSInhibrx Announces $200 Million Private Placement Financing
      8/07/202316:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
      8/07/202316:00PRNUSInhibrx Reports Second Quarter 2023 Financial Results and..
      5/30/202309:46DJNInhibrx Granted FDA Fast Track Designation for INBRX-101
      5/30/202309:00PRNUSInhibrx Granted Fast Track Designation for INBRX-101 for the..
      5/08/202316:05PRNUSInhibrx Reports First Quarter 2023 Financial Results and..
      4/26/202309:00PRNUSInhibrx Initiates a Registration-Enabling Trial of INBRX-101..

      Your Recent History

      NASDAQ
      INBX
      Inhibrx
      Delayed Upgrade Clock